New Coronavirus 2019 (nCoV-2019): Origin and Pathogenicity Mechanism

Sefidbakht, Yahya; Ghasemlou, Abdurahman; Rezaei, Shokouh

New Coronavirus 2019 (nCoV-2019): Origin and Pathogenicity Mechanism

Document Type : Promotion Article

Authors

¹ Protein Research Center, Shahid Beheshti University, Velenjak, Tehran, Iran.Faculty of New Technologies and Energy Engineering, Shahid Beheshti University, Velenjak, Tehran, Iran.

² Faculty of Biological Sciences, Shahid Behesti University, Tehran, Iran

Abstract

Currently, nCoV-2019 has affected more than 100 countries around the world, including Iran. This widespread epidemic has caused concern in the scientific and medical community because little information is available about the new virus and there is no specific treatment for it. Therefore, in this article we tried to give deeper information about virus of possible origin of the new coronavirus and its relationship with other previous coronaviruses. So, the mechanism of virus entry into the human cell and the factors involved in this process, such as virus proteins, are described. Other information presented here includes clinical signs of the disease and laboratory methods for detecting the virus, the stability of the virus at different levels, the zoonotic transmission, preventive measures such as strengthening the immune system and and treatment strategies such as plasma therapy. Also, this study provides evidence of amino acid changes in genomic specimens, the creation of new species, and the possibility that the virus may develop or be laboratory. Finally, some of the issues that remain unclear are discussed here.

Keywords

20.1001.1.2008935.1399.10.2.4.2

References

[1]. Remuzzi A, Remuzzi G. (2020). COVID-19 and Italy: what next? .The Lancet, 395(10231), 1225-1228.
[2]. Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, Pan P, Wang W, Hu D, Liu X, Zhang Q, Wu J. (2020). Coronavirus infections and immune responses. Journal of Medical Virology, 92(4), 424-432.
[3]. Su S, Wong G, Shi W, Liu J, Lai AC, Zhou J, Liu W, Bi W, Gao G. (2016). Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in Microbiology, 24(6), 490-502.
[4]. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, 395(10224), 565-574.
[5]. Li J-Y, You Z, Wang Q, Zhou Z-J, Qiu Y, Luo R, Ge X-Y. (2020). The epidemic of 2019-novel-coronavirus [2019-nCoV] pneumonia and insights for emerging infectious diseases in the future. Microbes and Infection, 22(2), 80-85.
[6]. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, Chen H-D, Chen J, Luo Y, Guo H, Jiang R-D, Liu M-Q, Chen Y, Shen X-R, Wang Xi, Zheng X-S, Zhao K, Chen Q-J, Deng F, Liu L-L, Yan B, Zhan F-X, Wang Y-Y, Xiao G-F, Shi Z-L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270-273.
[7]. Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Song Z-G, Hu Y, Tao Z-W, Tian J-H, Pei Y-Y, Yuan M-L, Zhang Y-L, Dai F-H, Liu Y, Wang Q-M, Zheng J-J, Xu L, Holmes E, Zhang Y-Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265-269.
[8]. Ji W, Wang W, Zhao X, Zai J, Li X. (2020). Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human. Journal of Medical Virology. doi.org/10.1002/jmv.25682
[9]. Ji W, Wang W, Zhao X, Zai J, Li X. (2020). Cross-species transmission of the newly identified coronavirus 2019-nCoV. Journal of Medical Virology, 92(4), 433-440.
[10]. Nadeem MS, Zamzami MA, Choudhry H, Murtaza BN, Kazmi I, Ahmad H, Shakoori AR. (2020). Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19). Pathogens, 9(4), 307. https://doi.org/10.3390/pathogens9040307
[11]. Walls A-C, Park Y-J, Tortorici M-A, Wall A, McGuire A-T, Veesler D. (2020). Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 181(2), 281-292.
[12]. Hoffmann M, Kleine-Weber H, Krüger N, Mueller MA, Drosten C, Pöhlmann S. (2020). The novel coronavirus 2019 [2019-nCoV] uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells, BioRxiv. doi.org/10.1101/2020.01.31.929042
[13]. Qi F, Qian S, Zhang S, Zhang Z. (2020). Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochemical and Biophysical Research Communications, 526(1), 135-140.
[14]. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
[15]. Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. (2020). Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology, 295(3), 715–721.
[16]. Yin Y, Wunderink RG. (2018). MERS, SARS and other coronaviruses as causes of pneumonia. Respirology, 23(2), 130-137.
[17]. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK,et al.(2020). Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.Eurosurveillance,25(3).https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045
[18]. Song F, Shi N, Shan F, Zhang Z, Shen J, Lu H, et al. (2020). Emerging 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology, 295(1), 210-217.
[19]. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. (2020). The proximal origin of SARS-CoV-2. Nature Medicine, 26(4), 450-452.
[20]. Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. (2020). Association between ABO blood groups and risk of SARS‐CoV‐2 pneumonia. British Journal of Haematology. https://doi.org/10.1111/bjh.16797
[21]. Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. (2020). Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine, 382(16), 1564-1567.
[22]. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. (2020) COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research, 24, 91-98.
[23]. Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B, Liu R, He X, Shuai L, Sun Z, Zhao Y. (2020). Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science, 368(6494), 1016-1020.
[24]. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. (2020). Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proceedings of the National Academy of Sciences, 117(17), 9490-9496.
[۲۵]. یوسفی، رضا، موسوی موحدی، فائزه ، (1398)، ویروس کرونای جدید: از پیشگیری و درمان تا ساز و کار تکثیر و گسترش در بدن انسان، نشریه نشاء علم، سال دهم، شماره اول، صفحات 42-53.